Posts tagged: preventing mother to child transmission

Empowering Women and Their Participation in the Fight against HV/AIDS

The month of March is special because it is the month when we celebrate International Women’s Day (IWD). It is the day when we all express our respect, appreciation and admiration for the women from all parts of the world. The United Nations decides on what theme the IWD will be focusing on, and this year it was “Empower Women – End Hunger and Poverty”.

Looking at the first part of the slogan, that is “Empower Women”, we find that a lot of the problems that we are facing in the world today could be solved by enforcing these two words. While empowering the women of the world and enabling them to be the main breadwinners of their homes will definitely be the tool to end hunger and poverty, it can also be the means by which mankind can defeat diseases that have been ravaging us for decades, a good example being HIV/AIDS.

As we all know, the most effective tool that has been found to combat this disease is awareness. For the better part of the last few decades, mankind has been dying from sheer lack of information on the disease. And even when it was discovered that people’s lives could be saved by simply informing them about the disease and its transmission methods, the number of new infections still kept rising. Read more »

Vitalwave™ – An Overview

Vitalwave™ is the application of photodisinfection to the birth canal. It is a therapy currently under development by OrGenX Biopharma Corporation and Ondine Biomedical Inc. for the prevention of mother-to-child transmission (PMTCT) of HIV. More than 90% of HIV infections in children are caused by mother-to-child transmission. This is the equivalent of 1,600 children becoming infected with HIV every day, or one child every minute1, affecting 1 out of every 4 babies born. Vitalwave™ is intended to bypass the stigma associated with AIDS, and designed to be safe, instantly effective and inexpensive to allow for universal deployment in resource-poor counties.

It is estimated that 13-38% of all pregnant women in South Africa are HIV positive1. Current estimates indicate that 90% of HIV-positive women in resource-poor settings do not have access to antiretroviral (ARV) medication on a regular basis and often reject treatment due to fear of the stigma-related threats of violence and abandonment. In the absence of ARV treatment, a pregnant woman has a 14-42% chance of passing HIV on to their child during labour and delivery2. A higher HIV vaginal viral load in the mother is associated with an increased risk of transmission to their unborn child. Vitalwave™ is currently being designed to safely and immediately reduce the HIV vaginal viral load to low levels.

Read more »

Related Posts Plugin for WordPress, Blogger...

Staypressed theme by Themocracy